Storage conditions : Store bag tightly closed between 5-30C (41-86F)
Whichever route you explore, make sure a licensed clinician reviews your history and oversees your treatment.
Elimination and the five-day half-life Tirzepatide has a terminal half-life of approximately five days (120 hours)
126 Co-administration of warfarin (a substrate of CYP1A2, CYP2C9, and CYP3A4) and octreotide led to high INR levels in humans, which may be attributed to the increased warfarin exposure caused by octreotides inhibitory effect on CYP3A4
Evaluate Progress at Key Milestones The 12-week mark is a pivotal moment in your treatment journey
Conversely, those who have recently gained weight due to life events like the pandemic, family matters, or lifestyle changes might benefit from temporary medication assistance to revert to healthier habits